ABL Bio Inc. (KOSDAQ: 298380)
South Korea
· Delayed Price · Currency is KRW
30,550
-950 (-3.02%)
Nov 19, 2024, 9:00 AM KST
ABL Bio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Nov '24 Nov 18, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,328,521 | 1,178,156 | 1,099,129 | 1,041,424 |
| Market Cap Growth | 64.03% | 7.19% | 5.54% | - |
| Enterprise Value | 1,396,729 | 1,126,398 | 1,038,936 | - |
| Last Close Price | 27650.00 | 24600.00 | 23000.00 | 22100.00 |
| PE Ratio | - | - | 342.55 | - |
| PS Ratio | 40.97 | 17.97 | 16.33 | 195.31 |
| PB Ratio | 8.24 | 15.90 | 15.81 | 18.61 |
| P/TBV Ratio | - | 16.47 | 16.43 | 19.50 |
| P/FCF Ratio | - | - | 15.68 | - |
| P/OCF Ratio | - | - | 15.24 | - |
| EV/Sales Ratio | 43.21 | 17.18 | 15.44 | - |
| EV/EBITDA Ratio | - | - | 321.37 | - |
| EV/EBIT Ratio | - | - | 1144.20 | - |
| EV/FCF Ratio | -17.16 | - | 14.83 | - |
| Debt / Equity Ratio | 0.24 | 0.59 | 0.60 | 0.01 |
| Debt / EBITDA Ratio | - | - | 12.94 | - |
| Debt / FCF Ratio | - | - | 0.60 | - |
| Asset Turnover | 0.15 | 0.38 | 0.54 | - |
| Quick Ratio | 7.71 | 1.71 | 1.09 | 5.01 |
| Current Ratio | 7.80 | 1.81 | 1.12 | 5.20 |
| Return on Equity (ROE) | -66.37% | -3.69% | 5.11% | - |
| Return on Assets (ROA) | -15.04% | -0.95% | 0.45% | - |
| Return on Capital (ROIC) | -17.93% | -1.43% | 0.68% | - |
| Earnings Yield | -6.68% | -0.22% | 0.29% | -4.18% |
| FCF Yield | -6.13% | -2.89% | 6.38% | -4.02% |
| Buyback Yield / Dilution | -0.05% | -0.58% | -1.27% | - |
| Total Shareholder Return | -0.05% | -0.58% | -1.27% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.